Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 1—January 2009

Past, Present, and Future of Japanese Encephalitis

Tobias E. ErlangerComments to Author , Svenja Weiss, Jennifer Keiser, Jürg Utzinger, and Karin Wiedenmayer
Author affiliations: Swiss Tropical Institute, Basel, Switzerland

Main Article

Table 1

First reported case and current situation of Japanese encephalitis in the main disease-endemic countries

Country First reported case Total population in rural JE-endemic areas (% of total)* Annual incidence† DALYs in 2002‡ Trend of JE incidence§ Vaccination program† National diagnostic center† References
Australia 1995 NA§ <1 <1¶ Stable Yes Yes (21)
Bangladesh 1977 106,385,000 (75) NA 24,000 Increasing No No (22)
Cambodia 1965# 11,293,000 (80) NA 4,000 Increasing No NA (23)
China 1940 422,532,000 (32) 8,000–10,000 281,000 Decreasing Yes Yes (18)
India 1955 597,542,000 (54) 1,500–4,000 226,000 Increasing No Yes (24)
Indonesia 1960 116,114,000 (52) NA 23,000 Increasing No NA (25)
Japan 1924 43,969,000 (34) <10** <1 Stable Yes Yes (26)
North Korea 1933 8,606,000 (38) NA 6,000 NA NA NA (27)
South Korea 1933 9,194,000 (19) <20 6,000 Stable Yes Yes (27)
Laos 1989 4,643,000 (78) NA 5,000 Increasing No Yes (28)
Malaysia 1952†† 8,854,000 (35) 50–100 2,000 Decreasing Yes Yes (29)
Myanmar 1965 35,077,000 (69) NA 13,000 Increasing No NA (18)
Nepal 1978 4,567,000 (20) 1,000–3,000 5,000 Stable Yes Yes (30)
Papua New Guinea 1995 5,109,000 (87) NA 2,000 NA NA NA (21)
Pakistan 1983 18,536,000 (12) NA 82,000 Increasing NA NA (27)
The Philippines 1950 31,081,000 (37) 10–50 8,000 Stable No Yes (19)
Singapore 1952 0 <1 260 Stable No Yes (31)
Sri Lanka 1968 16,381,000 (79) 100–200 1,000 Decreasing Yes Yes (32)
Thailand 1964 43,364,000 (68) 1,500–2,500 5,000 Decreasing Yes Yes (18,27)
Vietnam 1960 61,729,000 (73) 1,000–3,000 11,000 Stable Yes Yes (27,33)

*Japanese encephalitis (JE)–-endemic areas drawn from map provided in (34); rural population estimates derived from United Nations Urbanization Revisions (2).
†Information retrieved from questionnaires answered by employees from Ministry of Health and World Health Organization country offices.
‡Estimates for 2002 from World Health Organization (20). DALYs, disability-adjusted life years.
§<1% of the country is JE-endemic (Torres Straight islands, Cape York Peninsula). NA, not available.
¶Two deaths since 1995 (35).
#Virus isolated from mosquito (29).
**JE cases are very rare; highest risk is on Okinawa, Miyako, and Ishigaki islands. Between 1995 and 2005, 3 cases were reported (all in 2002) (26).
††First isolated from humans. During World War II, an outbreak that was probably due to JE occurred (31).

Main Article

  1. Solomon  T. Control of Japanese encephalitis–within our grasp? N Engl J Med. 2006;355:86971. DOIPubMedGoogle Scholar
  2. United Nations. The United Nations urbanization prospects: the 2005 revision. POP/DB/WUP/Rev.2005/1/F1. New York: United Nations; 2005.
  3. World Health Organization. World health report. (for years 2000–2004) [cited 2008 Oct 14]. Available from
  4. Solomon  T, Dung  NM, Kneen  R, Gainsborough  M, Vaughn  DW, Khanh  VT. Japanese encephalitis. J Neurol Neurosurg Psychiatry. 2000;68:40515. DOIPubMedGoogle Scholar
  5. Vaughn  DW, Hoke  CH Jr. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev. 1992;14:197221.PubMedGoogle Scholar
  6. Mackenzie  JS, Gubler  DJ, Petersen  LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med. 2004;10:S98109. DOIPubMedGoogle Scholar
  7. Johansen  CA, van den Hurk  AF, Ritchie  SA, Zborowski  P, Nisbet  DJ, Paru  R, Isolation of Japanese encephalitis virus from mosquitoes (Diptera: Culicidae) collected in the Western Province of Papua New Guinea, 1997–1998. Am J Trop Med Hyg. 2000;62:6318.PubMedGoogle Scholar
  8. Igarashi  A. Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control. Curr Top Microbiol Immunol. 2002;267:13952.PubMedGoogle Scholar
  9. World Health Organization. Global Advisory Committee on Vaccine Safety. Wkly Epidemiol Rec. 2008;83:3744.PubMedGoogle Scholar
  10. Bharati  K, Vrati  S. Japanese encephalitis: development of new candidate vaccines. Expert Rev Anti Infect Ther. 2006;4:31324. DOIPubMedGoogle Scholar
  11. Tauber  E, Dewasthaly  S. Japanese encephalitis vaccines—needs, flaws and achievements. Biol Chem. 2008;389:54750. DOIPubMedGoogle Scholar
  12. Wada  Y. Strategies for control of Japanese encephalitis in rice production systems in developing countries. In: Vector-borne disease control in humans through rice agroecosystems management: proceedings of the Workshop on Reasearch and Training Needs in the Field of Integrated Vector-Borne Disease Control in Riceland Agroecosystems of Developing Countries, 1987 Mar 9–14. International Rice Research Institute in collaboration with the WHO/FAO/UNEP Panel of Experts on Environmental Management for Vector Control; 1987.
  13. Keiser  J, Maltese  MF, Erlanger  TE, Bos  R, Tanner  M, Singer  BH, Effect of irrigated rice agriculture on Japanese encephalitis, including challenges and opportunities for integrated vector management. Acta Trop. 2005;95:4057. DOIPubMedGoogle Scholar
  14. Rajendran  R, Reuben  R, Purushothaman  S, Veerapatran  R. Prospects and problems of intermittent irrigation for control of vector breeding in rice fields in southern India. Ann Trop Med Parasitol. 1995;89:5419.PubMedGoogle Scholar
  15. World Health Organization. WHO position statement on integrated vector management. Wkly Epidemiol Rec. 2008;83:17781.PubMedGoogle Scholar
  16. Karunaratne  SH, Hemingway  J. Insecticide resistance spectra and resistance mechanisms in populations of Japanese encephalitis vector mosquitoes, Culex tritaeniorhynchus and Cx. gelidus, in Sri Lanka. Med Vet Entomol. 2000;14:4306. DOIPubMedGoogle Scholar
  17. Solomon  T, Ni  H, Beasley  DW, Ekkelenkamp  M, Cardosa  MJ, Barrett  AD. Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol. 2003;77:30918. DOIPubMedGoogle Scholar
  18. Tsai  TF. Japanese encephalitis vaccines. 1990 [cited 2008 Jul 30]. Available from
  19. Barzaga  NG. A review of Japanese encephalitis cases in the Philippines (1972–1985). Southeast Asian J Trop Med Public Health. 1989;20:58792.PubMedGoogle Scholar
  20. Murray  CJL, Salomon  JA, Mathers  CD, Lopez  AD, eds. Burden of disease statistics. 2004 [cited 2008 Jul 30]. Available from:
  21. Hanna  JN, Ritchie  SA, Phillips  DA, Shield  J, Bailey  MC, Mackenzie  JS, An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust. 1996;165:25660.PubMedGoogle Scholar
  22. Khan  AM, Khan  AQ, Dobrzynski  L, Joshi  GP, Myat  A. A Japanese encephalitis focus in Bangladesh. J Trop Med Hyg. 1981;84:414.PubMedGoogle Scholar
  23. Srey  VH, Sadones  H, Ong  S, Mam  M, Yim  C, Sor  S, Etiology of encephalitis syndrome among hospitalized children and adults in Takeo, Cambodia, 1999–2000. Am J Trop Med Hyg. 2002;66:2007.PubMedGoogle Scholar
  24. Kabilan  L, Rajendran  R, Arunachalam  N, Ramesh  S, Srinivasan  S, Samuel  PP, Japanese encephalitis in India: an overview. Indian J Pediatr. 2004;71:60915. DOIPubMedGoogle Scholar
  25. Sumarmo  SW, Suroso  T. Japanese encephalitis in Indonesia. Southeast Asian J Trop Med Public Health. 1995;26(Suppl 3):247.
  26. Kuwayama  M, Ito  M, Takao  S, Shimazu  Y, Fukuda  S, Miyazaki  K, Japanese encephalitis virus in meningitis patients, Japan. Emerg Infect Dis. 2005;11:4713.PubMedGoogle Scholar
  27. Solomon  T. Vaccines against Japanese encephalitis. In: Jong EC, Zuckerman JN, editors. Travelers vaccines. Hamilton (Canada): B.C. Decker; 2004. p. 219–56.
  28. Vongxay  P. Epidemiology of Japanese encephalitis in Lao PDR. Southeast Asian J Trop Med Public Health. 1995;26(Suppl 3):2830.
  29. Chastel  C, Rageau  J. Isolement d’arbovirus au Cambodge à partir de moustiques naturellement infectés. Med Trop (Mars). 1966;26:391400.PubMedGoogle Scholar
  30. Ministry of Health Nepal. Annual report of the Department of Health Services. Katmandu (Nepal): Ministry of Health, Nepal; 2005.
  31. Hale  JH. Serological evidence of the incidence of Japanese B encephalitis virus infection in Malaysia. Ann Trop Med Parasitol. 1955;49:2938.PubMedGoogle Scholar
  32. Abeysinghe  MRN. Ministry of Healthcare, Nutrition & Uva Wellassa Development. Weekly Epidemiological Record of Sri Lanka. MoH Sri Lanka Weekly Epidemiological Report; 2005;32.
  33. Nguyen  HT, Nguyen  TY. Japanese encephalitis in Vietnam 1985–1993. Southeast Asian J Trop Med Public Health. 1995;26(Suppl 3):4750.PubMedGoogle Scholar
  34. Tsai  TR, Chang  GW, Yu  YX. Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, editors. Philadelphia: WB Saunders, Inc.; 1999. p. 672–710.
  35. Johansen  CA, van den Hurk  AF, Pyke  AT, Zborowski  P, Phillips  DA, Mackenzie  JS, Entomological investigations of an outbreak of Japanese encephalitis virus in the Torres Strait, Australia, in 1998. J Med Entomol. 2001;38:5818.PubMedGoogle Scholar
  36. Tsai  TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine. 2000;18(Suppl. 2):125. DOIPubMedGoogle Scholar
  37. Food and Agricultural Organization. FAOSTAT: FAO statistical online database. 2008 [cited 2008 Feb 1]. Available from
  38. Gubler  DJ. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? Comp Immunol Microbiol Infect Dis. 2004;27:31930. DOIPubMedGoogle Scholar
  39. Sutherst  RW. Global change and human vulnerability to vector-borne diseases. Clin Microbiol Rev. 2004;17:13673. DOIPubMedGoogle Scholar
  40. Liu  W, Clemens  JD, Yang  JY, Xu  ZY. Immunization against Japanese encephalitis in China: a policy analysis. Vaccine. 2006;24:517882. DOIPubMedGoogle Scholar

Main Article

Page created: November 19, 2010
Page updated: November 19, 2010
Page reviewed: November 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.